The Effect of Mometasone Furoate Nasal Spray on Adenoid Hypertrophy and Its Related Obstructive Sleep Apnea in Pediatric Age Group

2011 ◽  
Vol 3 (10) ◽  
pp. 1-3 ◽  
Author(s):  
Dr.Ayaz Rehman ◽  
◽  
Dr.Riyaz A Malla ◽  
Dr.Sajad Hamid ◽  
Dr.Mushtaq Sangoo
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Nasal Spray ◽  
Mometasone Furoate ◽  
Adenoid Hypertrophy ◽  
Age Group ◽  
Pediatric Age ◽  
Pediatric Age Group ◽  
Obstructive Sleep

Uvulopalatopharyngoplasty in a child with obstructive sleep apnea

1988 ◽  
Vol 102 (6) ◽  
pp. 546-548 ◽  
Author(s):  
Mufid H. Abdu ◽  
Joseph G. Feghali
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Sleep Apnea Syndrome ◽  
Age Group ◽  
Pediatric Age ◽  
Pediatric Age Group ◽  
Obstructive Sleep ◽  
Apnea Syndrome ◽  
One Year

Abstract Uvulopalotopharyngoplasty (UPPP) has been recently popularized for the treatment of snoring and sleep apnea syndrome (SAS). All reported cases so far have been adults and the use of this procedure in the pediatric age group has not as yet been reported. Obstructive sleep apnea in children has been classically treated previously either medically or by adeno-tonsillectomy. The case of a three year old child with obstructive sleep apnea secondary to a large uvula and a redundant soft palate is reported. The child was successfully treated by UPPP, and remained free of symptoms for a follow-up period of one year.

scholarly journals Role of mometasone furoate nasal spray in children with adenoid hypertrophy: impact on life style changes

2020 ◽  
Vol 6 (9) ◽  
pp. 1709
Author(s):  
Venkatesha B. K. ◽  
Ravi Shekhar
Keyword(s):  
Nasal Obstruction ◽  
Nasal Spray ◽  
Statistical Tests ◽  
Nasal Congestion ◽  
Sleep Apnea Syndrome ◽  
Mometasone Furoate ◽  
Nasal Discharge ◽  
Adenoid Hypertrophy ◽  
Obstructive Sleep ◽  
Life Style Changes

<p class="abstract"><strong>Background:</strong> Adenoid hypertrophy (AH) is a common cause of upper airway obstruction and obstructive sleep apnea syndrome (OSAS) in children having major impact on child’s growth and development. Symptoms like nasal congestion, mouth breathing, nasal discharge, snoring, day time sleepiness, hyponasal voice, ear popping, and craniofacial abnormalities are observed. Adenoidectomy is considered the treatment of choice for symptomatic children. Co-existing medical illnesses and choice of surgical treatment is governed by the paediatricians and apprehensive parents. Need for conservative treatments in alleviating symptoms have been tried. Topical, intranasal administered, steroid preparations have been proven effective in the literature.</p><p class="abstract"><strong>Methods:</strong> In this prospective study, 35 symptomatic children (3-12 years) with adenoid hypertrophy were included. Each of the symptoms was scored from 0 (absent) to 4 (severe) over Visual Analogue Scale (VAS). Nasal obstruction index was calculated. Results of mometasone furoate nasal spray 100 microgram/day used once daily at the interval of 8 weeks and 12 weeks were analysed using statistical tests.  </p><p class="abstract"><strong>Results:</strong> A statistically significant reduction in nasal obstruction index and other symptoms were noted at the end of third month follow up.</p><p class="abstract"><strong>Conclusions:</strong> Mometasone furoate nasal spray caused improvements in outcomes of nasal obstruction, snoring, total nasal symptoms, ear symptoms and overall quality of life.</p>

Adenoid hypertrophy causing obstructive sleep apnea in children after pharyngeal flap surgery

2019 ◽  
Vol 276 (12) ◽  
pp. 3413-3417 ◽  
Author(s):  
Mosaad Abdel-Aziz ◽  
Mahmoud El-Fouly ◽  
Essam A. A. Elmagd ◽  
Ahmed Nassar ◽  
Assem Abdel-Wahid
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Adenoid Hypertrophy ◽  
Flap Surgery ◽  
Obstructive Sleep ◽  
Pharyngeal Flap

scholarly journals PREVALENCE OF OBSTRUCTIVE SLEEP APNEA IN AN INDIAN POPULATION: USING STOPBANG QUESTIONNAIRE

2018 ◽  
Vol 11 (11) ◽  
pp. 100 ◽  
Author(s):  
Snigdha Pattanaik ◽  
Rajagopal R ◽  
Neeta Mohanty ◽  
Swati Pattanaik
Keyword(s):  
Quality Of Life ◽  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Clinical Symptoms ◽  
Age Groups ◽  
Age Group ◽  
Prime Concern ◽  
Obstructive Sleep ◽  
Significant Difference

Objective: Obstructive sleep apnea (OSA) is a condition characterized by complete/partial obstruction of the upper airway that disrupts normal sleep pattern. It has become highly prevalent and negatively affects the quality of life. Reports show ≥4% of men and ≥2% of women, and mostly, the obese individuals are affected by OSA. OSA is independently associated with an increased likelihood of hypertension, cardiovascular disease, and diminished quality of life. Hence, it becomes a prime concern for health-care personnel to diagnose it at earliest. A screening tool is necessary to stratify patients based on their clinical symptoms, their physical examinations, and their risk factors. Thus, this study was taken up to assess the prevalence of OSA using the STOP-Bang questionnaire.Methods: A total number of 1012 participants were selected using random sampling technique from various community health camps for the study. The participants were asked to fill in the STOP-Bang questionnaire. All questionnaire respondents were precisely briefed about this study in a face-to-face interview. Data obtained from the survey were subjected to statistics, and descriptive analysis was done.Results: The prevalence of OSA was found to be 13.7% by using the Stop Bang questionnaire. It was found that the prevalence of OSA was highest in the age group of 50–59 (21.7%) and least in the age group of 18–29 (12.0%). Gender-wise distribution of OSA based on the scoring was seen to be more, among males (14.8%) and females showed a prevalence of 12.9%.Conclusion: This study concludes that the STOP-Bang method of screening showed a prevalence of 13.7%. However, the prevalence of OSA did not show any significant difference in various age groups; it was found that males had a higher prevalence of OSA compared to females.

scholarly journals Life-Threatening Obstructive Sleep Apnea Caused by Adenoid Hypertrophy in an Infant with Noonan Syndrome

2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Sonia Khirani ◽  
Nicolas Leboulanger ◽  
Adriana Ramirez ◽  
Brigitte Fauroux
Keyword(s):  
Risk Factors ◽  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Noonan Syndrome ◽  
Clinical History ◽  
Respiratory Morbidity ◽  
Adenoid Hypertrophy ◽  
Obstructive Sleep ◽  
Life Threatening ◽  
Obstructive Sleep Apneas

Adenoidectomy is a commonly performed surgery in children, even though its effectiveness is still under investigation. However, in children with risk factors such as age under 3 years old, associated comorbidities, or severe obstructive sleep apneas, a high postoperative respiratory morbidity is possible. We report the case of a 15-month-old boy with Noonan syndrome and a complex clinical history, who presented with a life-threatening obstructive sleep apnea due to hypertrophy of the adenoids which resolved completely after adenoidectomy.

Sign in / Sign up

Export Citation Format

Share Document